These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biotechs for pennies? Jacobs T Nat Biotechnol; 2004 Dec; 22(12):1509. PubMed ID: 15583652 [No Abstract] [Full Text] [Related]
3. Biotechs hold their own in shifting industry. Mitchell P Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238 [No Abstract] [Full Text] [Related]
8. Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off. McLean B Fortune; 2000 Jan; 141(1):132-4, 135. PubMed ID: 10788044 [No Abstract] [Full Text] [Related]
10. Korean biotechs seize opportunity to list on public markets. Louët S Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042 [No Abstract] [Full Text] [Related]
11. Biotechs feel the pain. Ledford H Nature; 2009 Jan; 457(7226):136-7. PubMed ID: 19129814 [No Abstract] [Full Text] [Related]
15. US venture capital for biotechnology. Dibner MD; Trull M; Howell M Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144 [No Abstract] [Full Text] [Related]
16. Biotechs await single European financial market. Louët S Nat Biotechnol; 2003 Dec; 21(12):1417. PubMed ID: 14647312 [No Abstract] [Full Text] [Related]